Estrogen's role in Alzheimer's disease has been a subject of significant research. Estrogen, a hormone primarily associated with female reproductive health, also influences brain function, including memory and cognition. Studies suggest that estrogen may have neuroprotective effects, potentially reducing the risk of Alzheimer's disease in women. However, the relationship is complex, as estrogen's benefits seem to vary depending on age, timing of hormone exposure (such as menopausal status), and individual genetic factors. Some research indicates that estrogen therapy after menopause might help maintain cognitive function and reduce the risk of dementia. Yet, the use of estrogen therapy remains controversial due to associated risks, such as cardiovascular complications and certain types of cancer. Further research is crucial to clarify estrogen's precise role in Alzheimer's disease and to develop safer therapeutic strategies.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Association between APOE allele prevalence and Alzheimer's disease risk in Southwestern Uganda
Frank Balikoowa, African Research Center for Ageing & Dementia, Uganda
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China